Target intelligence / Profile preview

Autophagy-related protein (ATG) family (ATG protein)

Target
ATG protein
Molecular classification
Enzyme, Protein complex, Scaffold/adaptor protein, Other
01

Overview

Autophagy-associated proteins collectively refer to the suite of genes and proteins (predominantly called ATG proteins) that control and implement the biological process of autophagy, which is a conserved lysosome-dependent degradation pathway involved in cellular clearance and quality control. These proteins assemble into multiprotein complexes to regulate the initiation (e.g., ULK1/2, ATG13, FIP200), nucleation (e.g., Beclin-1, VPS34), expansion (e.g., ATG5, ATG7, ATG12, LC3), and completion (e.g., SNAREs, ATG4) of autophagosomes, as well as cargo recognition and fusion with lysosomes. Autophagy proteins are essential for cellular response to nutrient deprivation, clearance of damaged organelles, protein aggregates, and pathogens, and are implicated in a wide range of physiological and pathological processes, including cancer, neurodegeneration, infection, and inflammation. The term refers to a protein family/mechanistic module, not a single pharmacological target.

Other names
Autophagy regulatorsATG proteinsAutophagy machinery componentsMAP1LC3Ubiquitin-like conjugation proteins
02

Mechanism of action

Inhibition or activation of autophagy (e.g., mTOR inhibitors activate, lysosomal inhibitors block late steps) Modulation of autophagy initiation (ULK1/Beclin-1 targeting) Blockade of autophagosome-lysosome fusion Interference with autophagy-related signaling cascades

03

Biological functions

Autophagy (macroautophagy, microautophagy, chaperone-mediated autophagy)Cellular homeostasisOrganelle turnover (mitophagy, pexophagy, etc.)Protein aggregate clearance (aggrephagy)Cell death and survival pathwaysImmune response modulationResponse to nutrient starvation and stress
04

Disease associations

CancerNeurodegenerative diseases (e.g., Parkinson's, Alzheimer's)InflammationInfection (clearance of pathogens, e.g., viruses, bacteria)Cardiovascular diseaseMetabolic disorders
05

Safety considerations

Systemic autophagy inhibition can cause toxicity due to essential homeostatic rolesImmunosuppressionImpaired cellular quality control (aggregation, organelle dysfunction)Potential to promote tumor progression or resistance in certain contexts
06

Interacting drugs

Rapamycin

7 more in the full profile.

07

Biomarkers

LC3-IIp62/SQSTM1Beclin-1 levelsATG5-ATG12 conjugate levelsmRNA of ATG genes

Beyond the preview

Go deeper on Autophagy-related protein (ATG) family (ATG protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy-related protein (ATG) family (ATG protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call